Vital Transformation understands the implications of new medical procedures, technologies and policies. We measure their impact on current clinical practices in close collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.

The impact of health technology made simple


DIA Global 2018: Value Pricing Bootcamp: A Crash Course in How to Use Real World Evidence to Better Measure Outcomes and Evaluate New Innovative Therapies

24th June, Boston, USA
Duane Schulthess, Managing Director of Vital Transformation, and Luca Pani, former Director General of the Italian Medicine's Agency and currently a Faculty Member at the University of Miami, will run a 3 hour and 15 minute Short Course outlining how best to harness RWE to better understand the price, value, and impact of next generation therapies.

Info & Registration

Better Science, Better Health: Advanced Therapies – Opportunities and Challenges

14th November, London
A European perspective to accelerate Advanced Therapies.


DIA Value, Access and Regulatory Strategy Workshop

25 Oct 2017 8:00 AM – 26 Oct 2017 3:30 PM

Radisson Blu Steinentorstrasse 25 4001 Basel Switzerland



Real world big data for clinical research and drug development

December 30, 2017
The objective of this paper is to identify the extent to which real world data (RWD) is being utilized, or could be utilized, at scale in drug development. Through screening peer-reviewed literature, we have cited specific examples where RWD can be used for biomarker discovery or validation, gaining a new understanding of a disease or disease associations, discovering new markers for patient stratification and targeted therapies, new markers for identifying persons with a disease, and pharmacovigilance.

Digital Citizen, Digital Patient: Estonia’s upcoming – first-ever – EU Presidency will put eHealth high on the agenda

An interview with Ain Aaviksoo, Deputy General Secretary on eServices and Innovation, Ministry of Social Affairs, Estonia.

A key aim of the Presidency is to promote Digital Europe. In eHealth the goal will be to highlight how digital technologies can contribute to the sustainability and resilience of healthcare systems.

Reinventing the European Advanced Therapies Sector: An Interview with Eduardo Bravo

Vital Transformation recently interviewed TiGenix CEO Eduardo Bravo and President of the European Biopharmaceutical Enterprises (EBE) on the implications of this lack of liquidity in Europe.

Digital Citizen, Digital Patient: How EU-funded research can drive the digitisation of health systems in Europe

An interview with Peeter Ross, professor at Tallinn University of Technology

As a participant in eight different EU projects, Peeter Ross, professor at Tallinn University of Technology, can fairly be described as a veteran of European ehealth research.

Digital citizen, digital patient: EMIF is bringing the power of numbers to dementia research

An interview with Simon Lovestone, Professor of Translational Neuroscience at Oxford University, UK

Making data repositories visible and easy to access is transforming translational research in Alzheimer’s disease. “You can answer questions you couldn’t before,” says Simon Lovestone, academic lead of the programme

  • Nigel Hughes

Digital citizen, digital patient: EMIF makes it as good to give as to receive

An Interview with Nigel Hughes, Scientific Director, Quantitative Sciences at Janssen Research and Development

By removing barriers to data exchange, EMIF has provided potent demonstrations of the power of pooling resources in Alzheimer’s disease and metabolic disorders. These exemplars are incentivising data sharing, says Nigel Hughes



Better Science, Better Health
27-28th October 2015, US Congress, Washington DC
Resources now available

Reports, videos and more...

Universal health: Investing in Health and Wellbeing for All
June 29th-30th, RIGA
Resources now available

Videos and downloads

Webinar: MAPPs – New Tools for Decision Making
April 14th, 2015, 2-3pm CEST
Resources now available

Read the article

RWE and Health Data in the EU: viable public policy vs. political overreach
February 7, 2016 - by Duane Schulhtess, Managing Director, Vital Transformation

Read the article




Register now to receive all the latest news and events.



Visit our youtube channel to view all of our videos.

ADAPT SMART Webinar: "Adaptive Pathways and Eastern European countries"

ADAPT SMART Webinar: Implementing Real World Data to Make Adaptive Pathways Work

New Paths to Personalised Medicine: How MAPPs and Breakthrough Designation will impact Patients

Webinar Get Real PragMagic

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.